Orthofix (OFIX) delivered earnings and revenue surprises of -40.91% and -0.22%, respectively, for the quarter ended December ...

Q4 2025 Management View Massimo Calafiore, President and CEO, reported "strong consistent performance in Bone Growth Therapies and U.S. Limb Reconstruction" with double-digit net sales growth in the ...

Before we begin, please note that our remarks include forward-looking statements. All statements other than those of historical facts are forward-looking statements. Reconciliations to U.S. GAAP and ...

Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Orthofix Medical Inc. (NASDAQ: OFIX) breached their fiduciary duties to shareholders.

Orthofix has found itself a new leader after the board ousted its previous chief and other members of its C-suite earlier this year over what they described as “offensive conduct.” Massimo Calafiore ...

Orthofix is the first and only company in the U.S. to offer a free recycling program to its bone growth therapy patients LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a ...

LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal healing products, announces support for the continued U.S. Food and ...

Gonsalves joins Orthofix from Integra LifeSciences, a global provider of regenerative technologies, neurosurgical and extremity orthopedic solutions, where he served as Chief Commercial Officer. “Paul ...

CEO Massimo Calafiore highlighted that Q1 2025 net sales reached $189.2M, reflecting a 6% year-over-year growth on a constant currency basis. Adjusted EBITDA margin expansion exceeded expectations ...

LEWISVILLE, Texas & CARLSBAD, Calif.--(BUSINESS WIRE)--Orthofix (NASDAQ: OFIX), a global medical device company with a spine and orthopedics focus, and SeaSpine (NASDAQ: SPNE), a global medical ...

Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of Orthofix Medical Inc. (NASDAQ: OFIX).

Canaccord Genuity initiated coverage on Orthofix Medical (NASDAQ:OFIX), a medical device company focused on the development, manufacture and commercialization of technology for the surgical treatment ...